Elite in Ankylosing Spondylitis

Maxime A. Breban

Université De Versailles St Quentin En Yvelines, Île De France, 
Montigny-sur-loing, FR 
Elite in Ankylosing Spondylitis
Université De Versailles St Quentin En Yvelines, Île De France, 
Montigny-sur-loing, FR 
OverviewLocationsClinical Research

Overview

Maxime Breban practices in Montigny-sur-loing, France. Mr. Breban is rated as an Elite expert by MediFind in the treatment of Ankylosing Spondylitis. His top areas of expertise are Ankylosing Spondylitis, Arthritis, Axial Spondyloarthritis (AxSpA), and Reactive Arthritis.

His clinical research consists of co-authoring 116 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 34 articles in the study of Ankylosing Spondylitis.

Gender
Male

Locations

Université De Versailles St Quentin En Yvelines, Île De France, Montigny-sur-loing, France
Other Locations
Boulogne-billancourt, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

JAKINIB Study: 'Observational', Multicentre Trial Collecting Prospective and On-going Clinical and Laboratory Data for Patients Treated With JAK Inhibitors for Inflammatory Rheumatism According to EMA.
JAKINIB Study: 'Observational', Multicentre Trial Collecting Prospective and On-going Clinical and Laboratory Data for Patients Treated With JAK Inhibitors for Inflammatory Rheumatism According to EMA.
Enrollment Status: Active_not_recruiting
Publish Date: January 23, 2025
Intervention Type: Other
Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis
Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: November 18, 2024
Intervention Type: Drug, Biological
Study Drugs: Secukinumab, TNF blocker, Blood specimen
Study Phase: Phase 4
Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis
Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: August 09, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

116 Total Publications

Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.
Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.
Journal: BMJ open
Published: December 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Breban's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile